Results 31 to 40 of about 2,012,581 (282)

Prescription drug diversion, misuse, and abuse among people living with HIV: a scoping review protocol

open access: yesSystematic Reviews, 2020
Background Prescription drugs are controlled medicines due to their potential risks of being diverted, misused, and abused. Since the introduction of antiretroviral (ARVs) drugs, HIV is currently regarded as a chronic condition.
Buyisile Chibi   +2 more
doaj   +1 more source

Misuse of prescription medicines is as prevalent as the use of recreational drugs and novel psychoactive substances in Singapore: an unrecognised public health issue?

open access: yesSingapore Medical Journal, 2022
Introduction: Misuse of prescription medicines and the harms associated with such use are growing threats across the world. There is currently, however, limited data on the extent of prescription medicine misuse in Singapore and whether this is a current
Wui Ling Chan   +6 more
doaj   +1 more source

Misuse of "study drugs:" prevalence, consequences, and implications for policy

open access: yesSubstance Abuse Treatment, Prevention, and Policy, 2006
Background Non-medical/illegal use of prescription stimulants popularly have been referred to as "study drugs". This paper discusses the current prevalence and consequences of misuse of these drugs and implications of this information for drug policy ...
Spruijt-Metz Donna   +3 more
doaj   +1 more source

Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health

open access: yesFrontiers in Psychiatry, 2023
BackgroundBenzodiazepines and non-benzodiazepine hypnotics (z-drugs) are commonly prescribed for their anxiolytic and hypnotic properties, though they can also be misused.
R. Kathryn McHugh   +5 more
doaj   +1 more source

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

open access: yesHepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman   +4 more
wiley   +1 more source

Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study

open access: yesBMJ Open
Objective To evaluate co-prescribing of sedatives hypnotics and opioids.Design Retrospective study evaluating the association of patient characteristics and comorbidities with coprescribing.Setting and participants Using the national Merative MarketScan ...
Hui Zhao   +9 more
doaj   +1 more source

Exploring the Etiologic Factors and Dynamics of Prescription Drug Abuse in Southwest Virginia [PDF]

open access: yesHealth Promotion Perspectives, 2012
Background: Prescription drug abuse in Southwest Virginia is a serious problem affecting indi-viduals, families, and communities. The aim of this study was to characterize and understand the extent of the prescription drug abuse problem in Southwest ...
Kerry J Redican   +3 more
doaj   +1 more source

Editorial: Misuse and abuse of prescription drugs in custodial settings

open access: yesFrontiers in Psychiatry, 2023
Custodial settings, such as prisons and psychiatric hospitals, are meant to be places of rehabilitation and security. Beside the abuse of illicit drugs, a growing concern about these institutions is the misuse and abuse of prescription drugs. Prescription drug abuse is the use of a prescription medication in a way not intended by the prescriber.
Filippo Pirani   +4 more
openaire   +3 more sources

Prescription Drug Affordability Board newsletter

open access: yes, 2022
Oregon Prescription Drug Affordability Board.Covers OCLC #1356823819, OCLC #1375385138This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core  

Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy

open access: yesArchives of Public Health
Background Less than half of community pharmacies in the United States stock buprenorphine products indicated for the treatment of opioid use disorder. This lack of access to buprenorphine in community pharmacies is a significant barrier to care.
Tyler J. Varisco   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy